The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2019 | Real world evidence in lung cancer: pros, cons & potential

Name: Real world evidence in lung cancer: pros, cons & potential
Uploaded: 2019-01-24T00:00:00Z
Duration: 1 min 24 s
Description: Mick Peake, MD, of the University of Leicester, Leicester, UK, discusses the strengths, limitations and potential of real world evidence in lung cancer from the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland.

Mick Peake • 24 Jan 2019

BTOG 2019

Lung Cancer Mesothelioma Non-Small Cell Lung Cancer

Mick Peake, MD, of the University of Leicester, Leicester, UK, discusses the strengths, limitations and potential of real world evidence in lung cancer from the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland.